Literature DB >> 28642308

Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score.

Shamil Haroon1, Peymane Adab1, Richard D Riley2, David Fitzmaurice3, Rachel E Jordan4.   

Abstract

Chronic obstructive pulmonary disease (COPD) is greatly underdiagnosed worldwide and more efficient methods of case-finding are required. We developed and externally validated a risk score to identify undiagnosed COPD using primary care records.We conducted a retrospective cohort analysis of a pragmatic cluster randomised controlled case-finding trial in the West Midlands, UK. Participants aged 40-79 years with no prior diagnosis of COPD received a postal or opportunistic screening questionnaire. Those reporting chronic respiratory symptoms were assessed with spirometry. COPD was defined as presence of relevant symptoms with a post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio below the lower limit of normal. A risk score was developed using logistic regression with variables available from electronic health records for 2398 participants who returned a postal questionnaire. This was externally validated among 1097 participants who returned an opportunistic questionnaire to derive the c-statistic, and the sensitivity and specificity of cut-points.A risk score containing age, smoking status, dyspnoea, prescriptions of salbutamol and prescriptions of antibiotics discriminated between patients with and without undiagnosed COPD (c-statistic 0.74, 95% CI 0.68-0.80). A cut-point of ≥7.5% predicted risk had a sensitivity of 68.8% (95% CI 57.3-78.9%) and a specificity of 68.8% (95% CI 65.8.1-71.6%).A novel risk score using routine data from primary care electronic health records can identify patients at high risk for undiagnosed symptomatic COPD. This score could be integrated with clinical information systems to help primary care clinicians target patients for case-finding.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28642308     DOI: 10.1183/13993003.02191-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  A nationwide analysis on the effects of chronic obstructive pulmonary disease following primary total shoulder arthroplasty for glenohumeral osteoarthritis.

Authors:  Brandon Amirian; Kyrillos M Akhnoukh; Asad M Ashraf; Samuel J Swiggett; Francis E Rosato; Rushabh M Vakharia; Ramin Sadeghpour; Afshin E Razi
Journal:  Shoulder Elbow       Date:  2021-02-25

2.  Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.

Authors:  Kirsty Rhodes; Martin Jenkins; Enrico de Nigris; Magnus Aurivillius; Mario Ouwens
Journal:  BMC Med Res Methodol       Date:  2022-05-25       Impact factor: 4.612

3.  Pooled Cohort Probability Score for Subclinical Airflow Obstruction.

Authors:  Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Byron C Jaeger; Patricia A Cassano; Paulo H Chaves; David Couper; David R Jacobs; Ravi Kalhan; Robert Kaplan; Donald Lloyd-Jones; Anne B Newman; George O'Connor; Jason L Sanders; Benjamin M Smith; Yifei Sun; Jason G Umans; Wendy B White; Sachin Yende; Elizabeth C Oelsner
Journal:  Ann Am Thorac Soc       Date:  2022-08

4.  Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.

Authors:  Lee Gazourian; William B Thedinger; Shawn M Regis; Elizabeth J Pagura; Lori Lyn Price; Melissa Gawlik; Cristina F Stefanescu; Carla Lamb; Kimberly M Rieger-Christ; Harpreet Singh; Marcel Casasola; Alexander R Walker; Arashdeep Rupal; Avignat S Patel; Carolyn E Come; Ava M Sanayei; William P Long; Giulia S Rizzo; Andrea B McKee; George R Washko; Raul San Jose Estepar; Christoph Wald; Brady J McKee; Carey C Thomson; Timothy N Liesching
Journal:  Respir Med       Date:  2020-11-20       Impact factor: 3.415

5.  Understanding Practice Patterns of COPD: A Survey of Physicians in Nepal, Sri Lanka and Malaysia.

Authors:  Ramesh Chokhani; Abdul Razak Muttalif; Kirthi Gunasekera; Aniruddha Mukhopadhyay; Vaibhav Gaur; Jaideep Gogtay
Journal:  Pulm Ther       Date:  2021-04-15

6.  The stability of the ADO score among UK COPD patients from The Health Improvement Network.

Authors:  Spencer J Keene; Peymane Adab; Frank de Vries; Frits M E Franssen; Alice Sitch; James Martin; Tom Marshall; Rachel Jordan
Journal:  ERJ Open Res       Date:  2020-02-10

7.  Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care.

Authors:  Emma Ray; David Culliford; Helen Kruk; Kate Gillett; Mal North; Carla M Astles; Alexander Hicks; Matthew Johnson; Sharon Xiaowen Lin; Rosanna Orlando; Mike Thomas; Rachel E Jordan; David Price; Mita Konstantin; Tom M A Wilkinson
Journal:  NPJ Prim Care Respir Med       Date:  2021-02-11       Impact factor: 2.871

8.  Case-finding for COPD clinic acceptability to patients in GPs across Hampshire: a qualitative study.

Authors:  Danielle Rose; Emma Ray; Rachael H Summers; Melinda Taylor; Helen Kruk; Mal North; Kate Gillett; Mike Thomas; Tom M A Wilkinson
Journal:  NPJ Prim Care Respir Med       Date:  2021-02-04       Impact factor: 2.871

9.  Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.

Authors:  Jung Bok Lee; Yeon-Mok Oh; Jieun Kang; Jae Seung Lee; Sei Won Lee
Journal:  Respir Res       Date:  2021-02-12

10.  External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.

Authors:  Spencer J Keene; Rachel E Jordan; Frits Me Franssen; Frank de Vries; James Martin; Alice Sitch; Alice Margaret Turner; Andrew P Dickens; David Fitzmaurice; Peymane Adab
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.